Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MLAB
MLAB logo

MLAB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Mesa Laboratories Inc (MLAB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
95.100
1 Day change
0.16%
52 Week Range
113.990
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Mesa Laboratories Inc (MLAB) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators suggest a lack of clear upward momentum, and there are no significant positive catalysts or trading signals to support an immediate purchase. Holding off for now or exploring other opportunities may be more prudent.

Technical Analysis

The MACD is negatively expanding (-1.495), indicating bearish momentum. RSI is neutral at 24.529, and moving averages are converging, showing no clear trend. The stock is trading near the S1 support level (95.93), with resistance levels at 103.711 and above.

Positive Catalysts

  • No recent news or events to act as positive catalysts. No significant insider or hedge fund activity.

Neutral/Negative Catalysts

  • Bearish MACD, lack of upward momentum, and no recent news or trading trends to support a positive outlook. Stock has a 40% chance to decline -2.77% in the next day and -1.23% in the next week.

Financial Performance

No financial data available for analysis due to an error in the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Wall Street analysts forecast MLAB stock price to rise
2 Analyst Rating
Wall Street analysts forecast MLAB stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 94.950
sliders
Low
83
Averages
99
High
115
Current: 94.950
sliders
Low
83
Averages
99
High
115
Wells Fargo
Equal Weight
maintain
$83 -> $94
AI Analysis
2026-02-04
Reason
Wells Fargo
Price Target
$83 -> $94
AI Analysis
2026-02-04
maintain
Equal Weight
Reason
Wells Fargo raised the firm's price target on Mesa Labs to $94 from $83 and keeps an Equal Weight rating on the shares. The firm notes the company posted a solid beat on Q3 revenue and adjusted EBITDA, with strong margin expansion despite foreign-exchange headwinds. With numbers moving up, leverage down and management taking more shareholder-friendly steps, there's more room for valuation to re-rate, in Wells' view.
Wells Fargo
Equal Weight
maintain
$75 -> $83
2025-12-15
Reason
Wells Fargo
Price Target
$75 -> $83
2025-12-15
maintain
Equal Weight
Reason
Wells Fargo raised the firm's price target on Mesa Labs to $83 from $75 and keeps an Equal Weight rating on the shares. With U.S. policy uncertainty lifting on Pharma and forward growth expectations already well-anchored with room for upside, the firm likes the setup for Tools.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MLAB
Unlock Now

People Also Watch